| Year |
Citation |
Score |
| 2023 |
Wei Y, Erfani S, Schweer D, de Gouvea R, Qadir J, Shi J, Cheng K, Wu D, Craven R, Wu Y, Olivier T, Baldwin LA, Zhou B, Zhou Y, Zhao W, et al. Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies. Molecular Therapy Oncolytics. 28: 293-306. PMID 36911068 DOI: 10.1016/j.omto.2023.02.006 |
0.398 |
|
| 2022 |
Cornett K, Puderbaugh A, Back O, Craven R. GAPDH in neuroblastoma: Functions in metabolism and survival. Frontiers in Oncology. 12: 979683. PMID 36267982 DOI: 10.3389/fonc.2022.979683 |
0.31 |
|
| 2020 |
Zhang Y, Xu B, Shi J, Li J, Lu X, Xu L, Yang H, Hamad N, Wang C, Napier D, He S, Liu C, Liu Z, Qian H, Chen L, ... ... Craven R, et al. BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways. Cellular Oncology (Dordrecht). PMID 33006750 DOI: 10.1007/s13402-020-00537-1 |
0.311 |
|
| 2018 |
Hampton KK, Frazier H, Anderson K, Thibault O, Craven RJ. Insulin receptor plasma membrane levels increased by the progesterone receptor membrane component 1. Molecular Pharmacology. PMID 29674524 DOI: 10.1124/Mol.117.110510 |
0.379 |
|
| 2018 |
Craven R, Hampton KK. Insulin Receptor Levels Regulated by the Receptor- Associated Protein Progesterone Receptor Membrane Component 1 (PGRMC1) Journal of Nutritional Biology. 4: 189-195. DOI: 10.18314/jnb.v4i2.1081 |
0.356 |
|
| 2015 |
Hampton KK, Stewart R, Napier D, Claudio PP, Craven RJ. PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival. Advances in Lung Cancer (Irvine). 4: 37-51. PMID 27867772 DOI: 10.4236/alc.2015.43006 |
0.472 |
|
| 2014 |
Hampton KK, Craven RJ. Pathways driving the endocytosis of mutant and wild-type EGFR in cancer. Oncoscience. 1: 504-12. PMID 25594057 DOI: 10.18632/oncoscience.67 |
0.354 |
|
| 2014 |
Izzo NJ, Xu J, Zeng C, Kirk MJ, Mozzoni K, Silky C, Rehak C, Yurko R, Look G, Rishton G, Safferstein H, Cruchaga C, Goate A, Cahill MA, Arancio O, ... ... Craven R, et al. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity. Plos One. 9: e111899. PMID 25390692 DOI: 10.1371/Journal.Pone.0111899 |
0.369 |
|
| 2013 |
Mir SU, Schwarze SR, Jin L, Zhang J, Friend W, Miriyala S, St Clair D, Craven RJ. Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy. Autophagy. 9: 1566-78. PMID 24113030 DOI: 10.4161/auto.25889 |
0.47 |
|
| 2013 |
Jin L, Craven RJ. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor. Oncogene. 33: 326-35. PMID 23318459 DOI: 10.1038/onc.2012.589 |
0.455 |
|
| 2012 |
Breuer EK, Murph MM, Craven RJ. Biochemical pathways in cancer. Biochemistry Research International. 2012: 268504. PMID 23213529 DOI: 10.1155/2012/268504 |
0.366 |
|
| 2012 |
Mir SU, Jin L, Craven RJ. Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1. The Journal of Biological Chemistry. 287: 14494-501. PMID 22418433 DOI: 10.1074/jbc.M111.324921 |
0.482 |
|
| 2012 |
Ahmed IS, Chamberlain C, Craven RJ. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling. Expert Opinion On Drug Metabolism & Toxicology. 8: 361-70. PMID 22292588 DOI: 10.1517/17425255.2012.658367 |
0.748 |
|
| 2012 |
Mir SU, Ahmed IS, Arnold S, Craven RJ. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients. International Journal of Cancer. 131: E1-9. PMID 21918976 DOI: 10.1002/ijc.26432 |
0.74 |
|
| 2010 |
Ahmed IS, Rohe HJ, Twist KE, Craven RJ. Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. The Journal of Biological Chemistry. 285: 24775-82. PMID 20538600 DOI: 10.1074/Jbc.M110.134585 |
0.735 |
|
| 2010 |
Ahmed IS, Rohe HJ, Twist KE, Mattingly MN, Craven RJ. Progesterone receptor membrane component 1 (Pgrmc1): A heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule Journal of Pharmacology and Experimental Therapeutics. 333: 564-573. PMID 20164297 DOI: 10.1124/Jpet.109.164210 |
0.756 |
|
| 2010 |
Dietrich CS, Greenberg VL, DeSimone CP, Modesitt SC, van Nagell JR, Craven R, Zimmer SG. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines. Gynecologic Oncology. 116: 126-30. PMID 19875160 DOI: 10.1016/J.Ygyno.2009.09.039 |
0.449 |
|
| 2009 |
Yim EK, Peng G, Dai H, Hu R, Li K, Lu Y, Mills GB, Meric-Bernstam F, Hennessy BT, Craven RJ, Lin SY. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell. 15: 304-14. PMID 19345329 DOI: 10.1016/j.ccr.2009.02.012 |
0.416 |
|
| 2009 |
Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacology & Therapeutics. 121: 14-9. PMID 18992768 DOI: 10.1016/J.Pharmthera.2008.09.006 |
0.733 |
|
| 2008 |
Craven RJ. PGRMC1: a new biomarker for the estrogen receptor in breast cancer. Breast Cancer Research : Bcr. 10: 113. PMID 19090968 DOI: 10.1186/bcr2191 |
0.44 |
|
| 2007 |
Craven RJ, Mallory JC, Hand RA. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. The Journal of Biological Chemistry. 282: 36543-51. PMID 17954932 DOI: 10.1074/Jbc.M706770200 |
0.342 |
|
| 2007 |
Ranney MK, Ahmed IS, Potts KR, Craven RJ. Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochimica Et Biophysica Acta. 1772: 1103-11. PMID 17689225 DOI: 10.1016/j.bbadis.2007.06.004 |
0.717 |
|
| 2006 |
Crudden G, Chitti RE, Craven RJ. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. The Journal of Pharmacology and Experimental Therapeutics. 316: 448-55. PMID 16234411 DOI: 10.1124/jpet.105.094631 |
0.499 |
|
| 2005 |
Mallory JC, Crudden G, Oliva A, Saunders C, Stromberg A, Craven RJ. A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells. Molecular Pharmacology. 68: 1747-56. PMID 16150928 DOI: 10.1124/mol.105.016519 |
0.393 |
|
| 2005 |
Crudden G, Loesel R, Craven RJ. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 26: 142-6. PMID 15970648 DOI: 10.1159/000086485 |
0.439 |
|
| 2005 |
Mallory JC, Crudden G, Johnson BL, Mo C, Pierson CA, Bard M, Craven RJ. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Molecular and Cellular Biology. 25: 1669-79. PMID 15713626 DOI: 10.1128/MCB.25.5.1669-1679.2005 |
0.374 |
|
| 2004 |
Kurenova E, Xu LH, Yang X, Baldwin AS, Craven RJ, Hanks SK, Liu ZG, Cance WG. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Molecular and Cellular Biology. 24: 4361-71. PMID 15121855 DOI: 10.1128/Mcb.24.10.4361-4371.2004 |
0.465 |
|
| 2003 |
Hand RA, Craven RJ. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells. Journal of Cellular Biochemistry. 90: 534-47. PMID 14523988 DOI: 10.1002/Jcb.10648 |
0.416 |
|
| 2003 |
Yang XH, Hand RA, Livasy CA, Cance WG, Craven RJ. Overexpression of the receptor tyrosine kinase Tie-1 intracellular domain in breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 24: 61-9. PMID 12853700 DOI: 10.1159/000071078 |
0.405 |
|
| 2003 |
Craven RJ, Lightfoot H, Cance WG. A decade of tyrosine kinases: from gene discovery to therapeutics. Surgical Oncology. 12: 39-49. PMID 12689669 DOI: 10.1016/S0960-7404(03)00004-5 |
0.333 |
|
| 2003 |
Hand RA, Jia N, Bard M, Craven RJ. Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor. Eukaryotic Cell. 2: 306-17. PMID 12684380 DOI: 10.1128/Ec.2.2.306-317.2003 |
0.339 |
|
| 2003 |
Beviglia L, Golubovskaya V, Xu L, Yang X, Craven RJ, Cance WG. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. The Biochemical Journal. 373: 201-10. PMID 12659633 DOI: 10.1042/Bj20021846 |
0.339 |
|
| 2003 |
Meyer T, Xu L, Chang J, Liu ET, Craven RJ, Cance WG. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. International Journal of Cancer. 104: 139-46. PMID 12569567 DOI: 10.1002/Ijc.10925 |
0.414 |
|
| 2002 |
Golubovskaya V, Beviglia L, Xu LH, Earp HS, Craven R, Cance W. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. The Journal of Biological Chemistry. 277: 38978-87. PMID 12167618 DOI: 10.1074/Jbc.M205002200 |
0.556 |
|
| 2000 |
Xu LH, Yang X, Bradham CA, Brenner DA, Baldwin AS, Craven RJ, Cance WG. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. The Journal of Biological Chemistry. 275: 30597-604. PMID 10899173 DOI: 10.1074/Jbc.M910027199 |
0.378 |
|
| 1995 |
Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S, Varnum B, Liu ET, Cance WG. Receptor tyrosine kinases expressed in metastatic colon cancer. International Journal of Cancer. Journal International Du Cancer. 60: 791-7. PMID 7896447 DOI: 10.1002/Ijc.2910600611 |
0.376 |
|
| 1994 |
Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Annals of Surgical Oncology. 1: 18-27. PMID 7834423 DOI: 10.1007/Bf02303537 |
0.336 |
|
| 1993 |
Cance WG, Craven RJ, Weiner TM, Liu ET. Novel protein kinases expressed in human breast cancer. International Journal of Cancer. Journal International Du Cancer. 54: 571-7. PMID 8099900 DOI: 10.1002/Ijc.2910540409 |
0.308 |
|
| Show low-probability matches. |